Hannah Ivison
Primary Care · Jackson, MSNPI 1962901587
Payments from drug & device makers
Across 508 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Merck$946
- E.r. Squibb & Sons, L.L.C.$602
- Genentech USA, Inc.$469
- Bristol Myers Squibb$459
- Gilead$388
- plus $6K from 54 others
What the payments were for
- Food & beverage$9,36798%
- Education$1802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$128
How this compares
$9,547 in reported general payments places this provider in the 90th percentile of 80 primary care providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $20,033 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 139 | $3,976 |
| Fentanyl | 28 | $3,415 |
| Colestipol Hcl | 27 | $2,021 |
| Tamoxifen Citrate | 50 | $1,252 |
| Raloxifene Hcl | 43 | $1,140 |
| Letrozole | 86 | $1,105 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $867 |
| Morphine Sulfate ErMorphine Sulfate | 21 | $828 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 72 | $617 |
| Ondansetron OdtOndansetron | 22 | $491 |
| Hydroxyurea | 22 | $459 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 35 | $422 |
| Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12) | 29 | $363 |
| Ondansetron Hcl | 21 | $304 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $357 | $20,03321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 80 primary care providers in Mississippi.
Other primary care in Jackson
- Jana WelchJackson$2K
- Jeanne HohmanJackson$780
- Virginia PowellJackson$571
- April PerryJackson$460
- Geraldstine MillerJackson$370
- Tammie TillmanJackson$293
- Cullen ShowsJackson$138
- Alisha McArthur WilkesRidgeland$484K
- Katrina BlackardSouthaven$14K
- Sarah HarringtonTupelo$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.